Skip to search formSkip to main contentSkip to account menu

CG 4203

Known as: CG-4203 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

taprostene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
Effects of prostacyclin and taprostene in splanchnic artery occlusion shock.
Prostacyclin (PGI2) and taprostene (CG-4203) were studied in a highly lethal model of splanchnic artery occlusion (SAO) shock in… 
1988
1988
Salutary Effects of CG‐4203, a Novel, Stable Prostacyclin Analog, in Hemorrhagic Shock
Prostacyclin (PGI2) is a potent vasodilator, an inhibitor of platelet aggregation, and a membrane-stabilizing agent that has been… 
1988
1988
Protective effects of CG-4203, a novel stable prostacyclin analog, in traumatic shock.
1988
1988
Prevention of coagulation during hemodialysis by a combination of the stable prostacyclin analogue CG 4203 and low-dose heparin.
In certain situations heparin used during hemodialysis can increase the risk of bleeding. Various groups have suggested that this… 
1988
1988
Salutary effects of the prostacyclin analogue CG 4203 in lethal endotoxemia in rats.
1987
1987
Stimulation of the plasma fibrinolytic activity in rats by the prostacyclin analogue CG 4203.
1984
1984
Cardioprotective action of the new stable epoprostenol analogue CG 4203 in rat models of cardiac hypoxia and ischemia.
[(5Z,13E,9 alpha,11 alpha,15S)-2,3,4-Trinor - 1,5 - inter-m - phenylene - 6,9 - epoxy - 11,5 - dihydroxy - 15 - cyclohexyl - 16… 
1983
1983
Role of renin release in the hemodynamic, renal and dipsogenic actions of the prostacyclin analogue CG 4203 in conscious rats.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)